Cas:1095010-49-3 Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate manufacturer & supplier

Chemical Name:Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate

CAS.NO:1095010-49-3

Synonyms:1,3-Piperidinedicarboxylic acid, 5-hydroxy-, 3-ethyl 1-(phenylmethyl) ester;1-benzyl 3-ethyl 5-hydroxypiperidine-1,3-dicarboxylate;1-O-benzyl 3-O-ethyl 5-hydroxypiperidine-1,3-dicarboxylate;1-Benzyl 3-ethyl 5-hydroxy-1,3-piperidinedicarboxylate

Molecular Formula:C₁₆H₂₁NO₅

Molecular Weight:307.342

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:447.5±45.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.555

PSA:76.07000

Exact Mass:307.141968

LogP:1.43

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3-Piperidinedicarboxylic acid, 5-hydroxy-, 3-ethyl 1-(phenylmethyl) ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Benzyl 3-ethyl 5-hydroxy-1,3-piperidinedicarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl 3-ethyl 5-hydroxypiperidine-1,3-dicarboxylate Use and application,1-O-benzyl 3-O-ethyl 5-hydroxypiperidine-1,3-dicarboxylate technical grade,usp/ep/jp grade.

Related News: But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US. Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate manufacturer The company has now selected a single engineered iPSC clone, and generated and fully-characterized the master engineered iPSC bank for GMP production of FT819. Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate supplier Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate vendor Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.